Long-term response to regorafenib (REG) in patients with metastatic colorectal cancer (mCRC): A systematic literature review (SLR)

被引：0
|
作者：
Peeters, M. [1 ]
Pan, X. [2 ]
Koufopoulou, M. [3 ]
Arregui, M. [4 ]
Wissinger, E. [5 ]
Ostojic, H. [6 ]
Pisa, F. [7 ]
Kim, R. D. [8 ]
机构：
[1] Univ Hosp Antwerp, Ctr Oncol Res, Edegem, Belgium
[2] Bayer Healthcare Pharmaceut Inc, Real World Evidence Oncol, Whippany, NJ 07981 USA
[3] Cencora, Evidence Generat & Value Commun, London, England
[4] Cencora, Evidence Generat & Value Commun, Hannover, Germany
[5] Cencora, Evidence Generat & Value Commun, Conshohocken, PA USA
[6] Bayer Consumer Care AG, Global Med Affairs, Basel, Switzerland
[7] Bayer AG, Real World Evidence Oncol, Berlin, Germany
[8] H Lee Moffitt Canc Ctr & Res Inst, Gastrointestinal Oncol, Tampa, FL USA
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.05.075
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
64P
引用
收藏
页码：S30 / S31
页数：2
相关论文
共 50 条
  • [1] Real-world (RW) study of metastatic colorectal cancer (mCRC) patients (pts) with long-term response (LTR) to regorafenib (REG) in the USA: An updated analysis
    Kim, R. D.
    Pan, X.
    Zhang, Y.
    Lunacsek, O.
    Pisa, F.
    Ostojic, H.
    Peeters, M.
    ANNALS OF ONCOLOGY, 2024, 35 : S41 - S41
  • [2] Pharmacokinetics of regorafenib (REG) in the phase 3 CONCUR and CORRECT trials in patients (pts) with metastatic colorectal cancer (mCRC)
    Cleton, A.
    Sturm, I.
    Trnkova, Z. Jirakova
    Grevel, J.
    Fiala-Buskies, S.
    Lettieri, J.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 10 - 10
  • [3] Real-world (RW) study in patients (pts) with metastatic colorectal cancer (mCRC) with long-term responses to regorafenib in the USA.
    Kim, Richard D.
    Pan, Xiaoyun
    Ostojic, Helene
    Zhang, Yiqiao
    Lunacsek, Orsolya
    Pisa, Federica
    Peeters, Marc
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 48 - 48
  • [4] Trifluridine/tipiracil (FTD/TPI) and regorafenib (REG) in patients with metastatic colorectal cancer (mCRC): A single institution retrospective study
    Patel, Anuj K.
    Ng, Kimmie
    Duh, Mei Sheng
    Barghout, Victoria E.
    Lynn Huynh
    Yenikomshian, Mihran Ara
    Sharperson, Camara
    Brais, Lauren K.
    Fuchs, Charles S.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [5] Real-world adherence in patients with metastatic colorectal cancer (mCRC) treated with trifluridine/tipiracil (FTD/TPI) or regorafenib (REG).
    Patel, Anuj K.
    Barghout, Victoria
    Yenikomshian, Mihran Ara
    Germain, Guillaume
    Jacques, Philippe
    Laliberte, Francois
    Duh, Mei Sheng
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (30)
  • [6] Safety and tolerability of regorafenib (REG) in Italian patients: Subgroup analysis of the phase III CORRECT study in metastatic colorectal cancer (mCRC)
    Sobrero, Alberto F.
    Falcone, Alfredo
    Barone, Carlo
    Zaniboni, Alberto
    Clardlello, Fortunato
    Luppi, Gabriela
    Carteni, Giacomo
    Carpani, Daniela
    Curzlo, Daniela
    Boni, Corrado
    Siena, Salvatore
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [7] Real world (RW) use and outcomes of regorafenib (REG) flexible dosing in patients (pts) with metastatic colorectal cancer (mCRC) in Europe
    Peeters, Marc
    Chibaudel, Benoist
    Barzi, Afsaneh
    Ostojic, Helene
    Pan, Xiaoyun
    Yasuda, Marie
    Chen, Chi-Chang
    Multani, Jasjit
    Casey, Vicky
    Vassilev, Zdravko
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 47 - 47
  • [8] "No problem" health-related quality of life (HRQoL) in patients treated with regorafenib (Reg) for relapsed metastatic colorectal cancer (mCRC).
    Su, Yun
    Ostojic, Helene
    Jaeger, Savina
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [9] Regorafenib (REG) in progressive metastatic colorectal cancer (mCRC): Analysis of age subgroups in the phase III CORRECT trial
    van Cutsem, Eric
    Sobrero, Alberto
    Siena, Salvatore
    Falcone, Alfredo
    Ychou, Marc
    Humblet, Yves
    Bouche, Olivier
    Mineur, Laurent
    Barone, Carlo
    Adenis, Antoine
    Argiles, Guillem
    Yoshino, Takayuki
    Lenz, Heinz-Josef
    Goldberg, Richard M.
    Sargent, Daniel J.
    Cihon, Frank
    Wagner, Andrea
    Laurent, Dirk
    Cupit, Lisa
    Grothey, Axel
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [10] Circulating microRNAs in metastatic colorectal cancer (mCRC) patients (pts) treated with regorafenib
    Schirripa, M.
    Loupakis, F.
    Cremolini, C.
    Poliseno, L.
    Salvatore, L.
    Tuccoli, A.
    Antoniotti, C.
    D'Aurzio, R.
    Marmorino, F.
    Borelli, B.
    Rossini, D.
    Saettini, A.
    Gini, S.
    Moretto, R.
    Rizzo, I.
    Aquila, E. Dell'
    Pellegrini, M.
    Falcone, A.
    ANNALS OF ONCOLOGY, 2015, 26
12345